Niagen Bioscience (NASDAQ:NAGE) reported quarterly earnings of $0.01 per share which missed the analyst consensus estimate of $0.02 by 50 percent. This is a 75 percent decrease over earnings of $0.04 per share from the same period last year. The company reported quarterly sales of $29.785 million which missed the analyst consensus estimate of $30.690 million by 2.95 percent. This is a 4.28 percent decrease over sales of $31.117 million the same period last year.